Expression of epidermal-growth-factor receptor in the K562 cell line by transfection. Altered receptor biochemistry
- PMID: 2173908
- PMCID: PMC1149632
- DOI: 10.1042/bj2710785
Expression of epidermal-growth-factor receptor in the K562 cell line by transfection. Altered receptor biochemistry
Abstract
The epidermal-growth-factor (EGF) receptor was expressed in the human erythroleukaemic cell line K562 by transfection of the receptor cDNA. EGF-receptor biochemistry appears altered in the K562 transfectants. Autophosphorylation of the K562 receptor is not stimulated substantially by EGF. Tyrosine kinase activity of the receptor is high in the absence of EGF, whereas receptor affinity for EGF is low. K562 cells are shown to lack mRNA for transforming growth factor alpha (TGF alpha). Therefore autocrine stimulation of the K562 receptor, at least by TGF alpha, does not explain the observed receptor biochemistry. The K562 receptor is phosphorylated at a single major site in intact cells, a threonine residue that may be Thr-669. Possible mechanisms of regulation of the EGF receptor in the K562 transfectants are discussed.
Similar articles
-
A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis.Mol Cell Biol. 1987 Dec;7(12):4568-71. doi: 10.1128/mcb.7.12.4568-4571.1987. Mol Cell Biol. 1987. PMID: 3501826 Free PMC article.
-
Transmembrane signalling at the epidermal growth factor receptor. Positive regulation by the C-terminal phosphotyrosine residues.Biochem J. 1991 Jul 15;277 ( Pt 2)(Pt 2):305-11. doi: 10.1042/bj2770305. Biochem J. 1991. PMID: 1713444 Free PMC article.
-
Polyoma middle T antigen or v-src desensitizes human epidermal growth factor receptor function and interference by a monensin-resistant mutation in mouse Balb/3T3 cells.Exp Cell Res. 1992 Dec;203(2):456-65. doi: 10.1016/0014-4827(92)90021-y. Exp Cell Res. 1992. PMID: 1459205
-
Epidermal growth factor and its receptor.Mol Cell Endocrinol. 1987 Jun;51(3):169-86. doi: 10.1016/0303-7207(87)90027-x. Mol Cell Endocrinol. 1987. PMID: 3109978 Review.
-
The EGF/TGF alpha receptor in skin.J Invest Dermatol. 1990 Jun;94(6 Suppl):164S-170S. doi: 10.1111/1523-1747.ep12876141. J Invest Dermatol. 1990. PMID: 2191051 Review.
Cited by
-
Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia.Onco Targets Ther. 2016 Jul 20;9:4453-64. doi: 10.2147/OTT.S105664. eCollection 2016. Onco Targets Ther. 2016. PMID: 27499639 Free PMC article.
-
Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.Cytotherapy. 2013 Aug;15(8):986-98. doi: 10.1016/j.jcyt.2013.04.003. Cytotherapy. 2013. PMID: 23830234 Free PMC article.
-
Development and Assessment of 1,5-Diarylpyrazole/Oxime Hybrids Targeting EGFR and JNK-2 as Antiproliferative Agents: A Comprehensive Study through Synthesis, Molecular Docking, and Evaluation.Molecules. 2023 Sep 8;28(18):6521. doi: 10.3390/molecules28186521. Molecules. 2023. PMID: 37764297 Free PMC article.
-
Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells.PLoS One. 2011;6(12):e29014. doi: 10.1371/journal.pone.0029014. Epub 2011 Dec 22. PLoS One. 2011. PMID: 22216158 Free PMC article.
-
High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo.PLoS One. 2013;8(3):e58757. doi: 10.1371/journal.pone.0058757. Epub 2013 Mar 14. PLoS One. 2013. PMID: 23516552 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials